Eli Non Currrent Assets Other vs Net Receivables Analysis

LLY Stock  USD 779.00  10.12  1.28%   
Eli Lilly financial indicator trend analysis is much more than just examining Eli Lilly latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Eli Lilly is a good investment. Please check the relationship between Eli Lilly Non Currrent Assets Other and its Net Receivables accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Non Currrent Assets Other vs Net Receivables

Non Currrent Assets Other vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Eli Lilly Non Currrent Assets Other account and Net Receivables. At this time, the significance of the direction appears to have weak relationship.
The correlation between Eli Lilly's Non Currrent Assets Other and Net Receivables is 0.37. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Eli Lilly and, assuming nothing else is changed. The correlation between historical values of Eli Lilly's Non Currrent Assets Other and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Eli Lilly and are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Non Currrent Assets Other i.e., Eli Lilly's Non Currrent Assets Other and Net Receivables go up and down completely randomly.

Correlation Coefficient

0.37
Relationship DirectionPositive 
Relationship StrengthVery Weak

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Net Receivables

Most indicators from Eli Lilly's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Eli Lilly current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
At this time, Eli Lilly's Discontinued Operations is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.32 in 2024, whereas Selling General Administrative is likely to drop slightly above 5.7 B in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit21.0B21.9B27.0B28.4B
Total Revenue28.3B28.5B34.1B35.8B

Eli Lilly fundamental ratios Correlations

0.930.940.110.760.830.080.210.990.450.130.94-0.750.850.960.850.590.950.970.740.790.720.960.82-0.13-0.27
0.930.95-0.250.610.96-0.28-0.020.910.39-0.140.97-0.90.920.920.950.60.990.90.790.840.750.940.85-0.14-0.53
0.940.95-0.020.620.91-0.090.00.920.36-0.060.97-0.780.760.940.940.430.930.920.680.820.880.970.91-0.16-0.36
0.11-0.25-0.020.33-0.340.970.460.130.060.62-0.10.47-0.330.06-0.29-0.2-0.190.09-0.18-0.210.020.03-0.070.010.75
0.760.610.620.330.520.30.280.770.440.230.64-0.460.640.690.490.630.670.70.620.480.380.680.51-0.09-0.01
0.830.960.91-0.340.52-0.4-0.290.850.22-0.380.93-0.940.840.870.950.570.930.770.830.810.730.910.88-0.1-0.58
0.08-0.28-0.090.970.3-0.40.570.090.050.73-0.180.53-0.310.03-0.37-0.23-0.220.06-0.21-0.32-0.05-0.03-0.20.010.81
0.21-0.020.00.460.28-0.290.570.110.420.96-0.040.30.110.09-0.170.00.060.34-0.22-0.090.0-0.02-0.21-0.20.4
0.990.910.920.130.770.850.090.110.410.060.93-0.780.850.950.830.620.940.920.80.770.680.960.82-0.1-0.26
0.450.390.360.060.440.220.050.420.410.240.37-0.290.430.290.330.420.430.490.040.480.240.290.290.02-0.39
0.13-0.14-0.060.620.23-0.380.730.960.060.24-0.140.45-0.050.04-0.28-0.15-0.060.24-0.28-0.25-0.02-0.08-0.29-0.130.63
0.940.970.97-0.10.640.93-0.18-0.040.930.37-0.14-0.870.850.930.950.610.960.920.780.910.740.970.94-0.19-0.48
-0.75-0.9-0.780.47-0.46-0.940.530.3-0.78-0.290.45-0.87-0.89-0.76-0.87-0.75-0.89-0.69-0.84-0.85-0.5-0.8-0.80.040.73
0.850.920.76-0.330.640.84-0.310.110.850.43-0.050.85-0.890.810.810.780.950.830.810.780.460.80.66-0.1-0.55
0.960.920.940.060.690.870.030.090.950.290.040.93-0.760.810.850.520.930.930.750.750.770.960.83-0.03-0.24
0.850.950.94-0.290.490.95-0.37-0.170.830.33-0.280.95-0.870.810.850.470.930.840.680.870.780.910.89-0.17-0.6
0.590.60.43-0.20.630.57-0.230.00.620.42-0.150.61-0.750.780.520.470.660.510.760.70.020.530.510.0-0.49
0.950.990.93-0.190.670.93-0.220.060.940.43-0.060.96-0.890.950.930.930.660.930.80.850.690.940.83-0.13-0.49
0.970.90.920.090.70.770.060.340.920.490.240.92-0.690.830.930.840.510.930.610.790.740.910.79-0.18-0.27
0.740.790.68-0.180.620.83-0.21-0.220.80.04-0.280.78-0.840.810.750.680.760.80.610.650.370.790.7-0.17-0.4
0.790.840.82-0.210.480.81-0.32-0.090.770.48-0.250.91-0.850.780.750.870.70.850.790.650.530.820.89-0.15-0.65
0.720.750.880.020.380.73-0.050.00.680.24-0.020.74-0.50.460.770.780.020.690.740.370.530.770.74-0.19-0.18
0.960.940.970.030.680.91-0.03-0.020.960.29-0.080.97-0.80.80.960.910.530.940.910.790.820.770.9-0.17-0.34
0.820.850.91-0.070.510.88-0.2-0.210.820.29-0.290.94-0.80.660.830.890.510.830.790.70.890.740.9-0.17-0.47
-0.13-0.14-0.160.01-0.09-0.10.01-0.2-0.10.02-0.13-0.190.04-0.1-0.03-0.170.0-0.13-0.18-0.17-0.15-0.19-0.17-0.170.14
-0.27-0.53-0.360.75-0.01-0.580.810.4-0.26-0.390.63-0.480.73-0.55-0.24-0.6-0.49-0.49-0.27-0.4-0.65-0.18-0.34-0.470.14
Click cells to compare fundamentals

Eli Lilly Account Relationship Matchups

Eli Lilly fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets39.3B46.6B48.8B49.5B64.0B67.2B
Short Long Term Debt Total15.8B16.6B16.9B16.2B25.2B26.5B
Total Current Liabilities11.8B12.5B15.1B17.1B27.3B28.7B
Total Stockholder Equity2.6B5.6B9.0B10.6B10.8B9.0B
Property Plant And Equipment Net8.4B8.7B9.0B10.1B12.9B6.8B
Net Debt13.5B12.9B13.1B14.2B22.4B23.5B
Retained Earnings4.9B7.8B9.0B10.0B10.3B9.5B
Cash2.3B3.7B3.8B2.1B2.8B3.1B
Non Current Assets Total25.6B29.2B30.4B31.5B38.3B40.2B
Non Currrent Assets Other2.3B3.5B4.1B4.3B5.0B2.9B
Cash And Short Term Investments2.4B3.7B3.9B2.2B2.9B3.7B
Net Receivables5.5B6.9B8.1B8.6B11.3B11.9B
Common Stock Shares Outstanding935.7M912.5M911.7M904.6M903.3M868.4M
Liabilities And Stockholders Equity39.3B46.6B48.8B49.5B64.0B67.2B
Non Current Liabilities Total24.8B28.3B24.6B21.6B25.8B27.1B
Inventory3.2B4.0B3.9B4.3B5.8B6.1B
Other Current Assets2.5B2.9B2.5B3.0B5.7B6.0B
Other Stockholder Equity3.6B6.7B6.8B6.9B4.2B2.5B
Total Liab36.6B40.8B39.7B38.7B53.1B55.8B
Total Current Assets13.7B17.5B18.5B18.0B25.7B27.0B
Intangible Assets6.6B7.5B7.7B7.2B6.9B7.3B
Other Current Liab2.2B10.4B11.7B13.2B13.9B14.6B
Short Term Debt1.5B8.7M1.5B1.5B6.9B7.2B
Accounts Payable1.4B1.6B1.7B1.9B2.6B2.7B
Property Plant And Equipment Gross8.4B8.7B19.0B20.4B24.0B25.2B
Accumulated Other Comprehensive Income(6.5B)(6.5B)(4.3B)(3.8B)(4.3B)(4.5B)
Common Stock Total Equity661M598.8M598.2M594.1M534.7M494.1M
Short Term Investments101M24.2M90.1M144.8M109.1M103.6M
Capital Stock598.8M598.2M596.3M594.1M593.6M544.7M
Common Stock598.8M598.2M596.3M594.1M593.6M544.7M
Other Liab10.5B11.0B8.7B6.1B7.0B5.5B
Other Assets4.7B9.3B6.4B7.1B8.2B4.2B
Long Term Debt13.8B16.6B15.3B14.7B18.3B19.2B
Treasury Stock(60.8M)(55.7M)(52.7M)(50.5M)(44.2M)(46.4M)
Property Plant Equipment7.9B8.7B9.0B10.1B11.7B8.5B
Good Will3.7B3.8B3.9B4.1B4.9B2.9B
Current Deferred Revenue6.7B8.1B8.8B14.5B16.7B17.5B
Noncontrolling Interest In Consolidated Entity92.2M183.6M175.6M125.6M91.8M141.7M
Retained Earnings Total Equity13.9B11.4B4.9B10.0B11.5B10.8B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Eli Stock Analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.